PEOPLE - Myriad Genetic Laboratories (US) makes appointment:
This article was originally published in Clinica
Dr Thomas Frank has been named medical director and vice- president of education at Myriad Genetic Laboratories (US). He was formerly associate professor in the department of pathology at the University of Michigan School of Medicine.
You may also be interested in...
More patent-related turbulence appears ahead for Novartis’s sacubitril/valsartan combination in India, with Torrent emerging as the new challenger. The companies are engaged in a legal battle and the Indian firm is also seeking a revocation of the patent on the star heart failure treatment.
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.